The Hyperlipidemia Caused by Overuse of Glucocorticoid after Liver Transplantation and the Immune Adjustment Strategy
The overuse of glucocorticoid may cause the metabolic disorders affecting the long term outcome of liver transplantation. This study aims to investigate the immune adjustment strategy by decreasing use of glucocorticoid after liver transplantation. The follow-up study was carried out on liver functi...
Saved in:
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2017-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2017/3149426 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832566620339306496 |
---|---|
author | Xueqin Meng Xinhua Chen Liming Wu Shusen Zheng |
author_facet | Xueqin Meng Xinhua Chen Liming Wu Shusen Zheng |
author_sort | Xueqin Meng |
collection | DOAJ |
description | The overuse of glucocorticoid may cause the metabolic disorders affecting the long term outcome of liver transplantation. This study aims to investigate the immune adjustment strategy by decreasing use of glucocorticoid after liver transplantation. The follow-up study was carried out on liver function and lipid metabolism. This study included adult recipients of liver transplantation. There were 3 groups according to their use of glucocorticoid: long term (>3 months, n=18), short term (<3 months, n=20), and control group (no use of glucocorticoid, radical hepatic resection, n=22). The laboratory results of liver function (AST/ALT ratio) and serum lipid were compared 6 months after liver transplantation. AST/ALT ratio, the marker of liver function, showed no significant difference between long and short term group (P>0.05). The acute rejection had no significant difference between short and long term groups, while TG, HDL, LDL, and glucose showed significant change in the long term group (P<0.05). At 6 months after liver transplantation, the long term group showed higher metabolic disorders (P<0.05). The proper immune adjustment strategy should be made to avoid overuse of glucocorticoid. It can decrease hyperlipidemia and other metabolic disorders after liver transplantation without increasing the acute rejection or liver function damage. |
format | Article |
id | doaj-art-6c342c6421854a24ab3710b7748a351e |
institution | Kabale University |
issn | 2314-8861 2314-7156 |
language | English |
publishDate | 2017-01-01 |
publisher | Wiley |
record_format | Article |
series | Journal of Immunology Research |
spelling | doaj-art-6c342c6421854a24ab3710b7748a351e2025-02-03T01:03:36ZengWileyJournal of Immunology Research2314-88612314-71562017-01-01201710.1155/2017/31494263149426The Hyperlipidemia Caused by Overuse of Glucocorticoid after Liver Transplantation and the Immune Adjustment StrategyXueqin Meng0Xinhua Chen1Liming Wu2Shusen Zheng3Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University, Hangzhou 310003, ChinaCollaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University, Hangzhou 310003, ChinaCollaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University, Hangzhou 310003, ChinaCollaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University, Hangzhou 310003, ChinaThe overuse of glucocorticoid may cause the metabolic disorders affecting the long term outcome of liver transplantation. This study aims to investigate the immune adjustment strategy by decreasing use of glucocorticoid after liver transplantation. The follow-up study was carried out on liver function and lipid metabolism. This study included adult recipients of liver transplantation. There were 3 groups according to their use of glucocorticoid: long term (>3 months, n=18), short term (<3 months, n=20), and control group (no use of glucocorticoid, radical hepatic resection, n=22). The laboratory results of liver function (AST/ALT ratio) and serum lipid were compared 6 months after liver transplantation. AST/ALT ratio, the marker of liver function, showed no significant difference between long and short term group (P>0.05). The acute rejection had no significant difference between short and long term groups, while TG, HDL, LDL, and glucose showed significant change in the long term group (P<0.05). At 6 months after liver transplantation, the long term group showed higher metabolic disorders (P<0.05). The proper immune adjustment strategy should be made to avoid overuse of glucocorticoid. It can decrease hyperlipidemia and other metabolic disorders after liver transplantation without increasing the acute rejection or liver function damage.http://dx.doi.org/10.1155/2017/3149426 |
spellingShingle | Xueqin Meng Xinhua Chen Liming Wu Shusen Zheng The Hyperlipidemia Caused by Overuse of Glucocorticoid after Liver Transplantation and the Immune Adjustment Strategy Journal of Immunology Research |
title | The Hyperlipidemia Caused by Overuse of Glucocorticoid after Liver Transplantation and the Immune Adjustment Strategy |
title_full | The Hyperlipidemia Caused by Overuse of Glucocorticoid after Liver Transplantation and the Immune Adjustment Strategy |
title_fullStr | The Hyperlipidemia Caused by Overuse of Glucocorticoid after Liver Transplantation and the Immune Adjustment Strategy |
title_full_unstemmed | The Hyperlipidemia Caused by Overuse of Glucocorticoid after Liver Transplantation and the Immune Adjustment Strategy |
title_short | The Hyperlipidemia Caused by Overuse of Glucocorticoid after Liver Transplantation and the Immune Adjustment Strategy |
title_sort | hyperlipidemia caused by overuse of glucocorticoid after liver transplantation and the immune adjustment strategy |
url | http://dx.doi.org/10.1155/2017/3149426 |
work_keys_str_mv | AT xueqinmeng thehyperlipidemiacausedbyoveruseofglucocorticoidafterlivertransplantationandtheimmuneadjustmentstrategy AT xinhuachen thehyperlipidemiacausedbyoveruseofglucocorticoidafterlivertransplantationandtheimmuneadjustmentstrategy AT limingwu thehyperlipidemiacausedbyoveruseofglucocorticoidafterlivertransplantationandtheimmuneadjustmentstrategy AT shusenzheng thehyperlipidemiacausedbyoveruseofglucocorticoidafterlivertransplantationandtheimmuneadjustmentstrategy AT xueqinmeng hyperlipidemiacausedbyoveruseofglucocorticoidafterlivertransplantationandtheimmuneadjustmentstrategy AT xinhuachen hyperlipidemiacausedbyoveruseofglucocorticoidafterlivertransplantationandtheimmuneadjustmentstrategy AT limingwu hyperlipidemiacausedbyoveruseofglucocorticoidafterlivertransplantationandtheimmuneadjustmentstrategy AT shusenzheng hyperlipidemiacausedbyoveruseofglucocorticoidafterlivertransplantationandtheimmuneadjustmentstrategy |